Cadila Healthcare Limited has informed the Exchange regarding a press release dated September 18, 2020, titled "Zydus Cadila receives final approval from USFDA for Potassium Chloride Extended-Release Tablets".
Press Release Sep 18 2020
Filed with NSE ·
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Sep 11 2020
- Press Release Sep 09 2020
- Press Release Sep 03 2020
- Press Release Sep 02 2020
- Press Release Aug 13 2020
Later from Zydus Lifesciences
- Press Release Sep 24 2020
- Press Release Sep 25 2020
- Press Release Oct 08 2020
- Press Release Oct 16 2020
- Press Release Oct 17 2020
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences